1. Home >
  2. Companies >
  3. Life Science >
  4. France >
  5. H-Immune Therapeutics

H-Immune Therapeutics - Ownership and Business Overview

Life ScienceCompany

H-Immune Therapeutics Ownership

Who owns H-Immune Therapeutics?

H-Immune Therapeutics is owned by HiFiBiO Therapeutics. It was acquired on October 15, 2018.

H-Immune Therapeutics Business Overview

Where is H-Immune Therapeutics headquartered?

H-Immune Therapeutics is headquartered in Paris, France.

What sector is H-Immune Therapeutics in?

H-Immune Therapeutics is a life science company.

When was H-Immune Therapeutics founded?

H-Immune Therapeutics was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Subscribe to Mergr to view all 250 acquisitions of life science companies in 2018, including 46 acquisitions by private equity firms, and 204 by strategics.

H-Immune Therapeutics

Paris,
France,
www.h-immune.com

H-Immune Therapeutics is an early-stage biotechnology company engaged in the discovery and development of novel immuno-oncology therapeutics.


Company Summary

SECTOR

Life Science

Established

2016

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for H-Immune Therapeutics

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal